Ainoa Ugarte

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Venues

Infectious diseases and therapy

The Journal of antimicrobial chemotherapy

Antiviral therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ainoa Ugarte, Lorena De La Mora, Elisa De Lazzari, Iván Chivite, Emma Fernández, Alexy Inciarte, Montserrat Laguno, Juan Ambrosioni, Estela Solbes, Leire Berrocal, Ana González-Cordón, María Martínez-Rebollar, Alberto Foncillas, Júlia Calvo, José Luis Blanco, Esteban Martinez, Josep Mallolas, Berta Torres
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Ainoa Ugarte, Lorena De La Mora, Elisa De Lazzari, Iván Chivite, Emma Fernández, Alexy Inciarte, Montserrat Laguno, Juan Ambrosioni, Estela Solbes, Leire Berrocal, Ana González-Cordón, María Martínez-Rebollar, Alberto Foncillas, Júlia Calvo, José Luis Blanco, Esteban Martinez, Josep Mallolas, Berta Torres
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study. The Journal of antimicrobial chemotherapy (2024)
Ainoa Ugarte, Lorena de la Mora, David García, María Martínez-Rebollar, Elisa de Lazzari, Berta Torres, Alexy Inciarte, Juan Ambrosioni, Iván Chivite, Estela Solbes, Nicolás de Loredo, Guillermo Federico Del Carlo, Ana González-Cordón, José Luis Blanco, Esteban Martínez, Josep Mallolas, Montserrat Laguno
Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years' Experience. Infectious diseases and therapy (2022)
Ainoa Ugarte, Lorena de la Mora, David García, María Martínez-Rebollar, Elisa de Lazzari, Berta Torres, Alexy Inciarte, Juan Ambrosioni, Iván Chivite, Estela Solbes, Nicolás de Loredo, Guillermo Federico Del Carlo, Ana González-Cordón, José Luis Blanco, Esteban Martínez, Josep Mallolas, Montserrat Laguno
Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years' Experience. Infectious diseases and therapy 12 (2) (2022)
Ainoa Ugarte, Lorena de la Mora, David García, María Martínez-Rebollar, Elisa de Lazzari, Berta Torres, Alexy Inciarte, Juan Ambrosioni, Iván Chivite, Estela Solbes, Nicolás de Loredo, Guillermo Federico Del Carlo, Ana González-Cordón, José Luis Blanco, Esteban Martínez, Josep Mallolas, Montserrat Laguno
Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years' Experience. Infectious diseases and therapy (2022)
Ainoa Ugarte, Lorena De la Mora, María Martínez-Rebollar, Josep Mallolas, Montserrat Laguno
An unexpected adverse effect: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide-induced cholestasis. Antiviral therapy 26 (1-2) (2021)

Ainoa Ugarte.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ainoa Ugarte